Anuncio
Anuncio

PMCB

PMCB logo

PharmaCyte Biotech, Inc. Common Stock

0.59
USD
Patrocinado
0.00
0.00%
07 ago, 15:59 UTC -4
Cerrado
exchange

Post-mercado

0.59

0.00
+0.66%

Panorámica financiera de PharmaCyte Biotech, Inc. Common Stock

Cap. de Mercado
6.38M
Beta
0.57
Beneficios Por Acción (BPA)
-3.00
Ratio Precio/Valor (P/V) Contable
0.19
Margen de explotación
--
Ratio de Endeudamiento total (D/C)
0.00%
Ratio PER
--
Rentabilidad sobre recursos propios (ROE)
0.25%
Ratio de liquidez
45.28%
Flujo de caja libre
-5.15M
Perfil de PMCB

Gráfico de Beneficios

Beneficios de PMCB

Últimas noticias y pronósticos

Ver todo

Valores en tendencia

Space Exploration Technologies Corp. Class A Common Stock logo
Space Exploration Technologies Corp. Class A Common Stock$133.11
+15.83%
Micron Technology, Inc. logo
Micron Technology, Inc.$877.57
-0.44%
Nvidia Corp logo
Nvidia Corp$223.96
+2.27%
Sandisk Corporation Common Stock logo
Sandisk Corporation Common Stock$1,212.21
-3.68%
Palantir Technologies Inc. Class A Common Stock logo
Palantir Technologies Inc. Class A Common Stock$172.01
+10.32%
Tesla, Inc. Common Stock logo
Tesla, Inc. Common Stock$328.58
+2.83%
Advanced Micro Devices logo
Advanced Micro Devices$483.36
-1.21%
Anuncio